Stay updated on Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added recruitment notice 'No longer looking for participants' and new help/navigation sections including How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment heading. Old heading 'Intervention / Treatment' and the previous revision label 'v3.5.5' were removed and replaced with the current revision 'v3.6.0'.
    Difference
    0.4%
    Check dated 2026-06-15T20:05:47.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a new version of the page has been published. This appears to be a small system-level update rather than a change to the study data or its presentation.
    Difference
    0.1%
    Check dated 2026-06-08T16:46:16.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Reid Merryman, MD has been added to the investigators list (noted on 2026-05-18 and 2026-05-04) and Philippe Armand, MD, PhD has been removed (noted on 2026-02-12, 2026-01-26, and 2023-07).
    Difference
    0.4%
    Check dated 2026-05-25T08:14:34.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, signaling a minor build/version update. This change represents an update to the page's revision history without altering visible content or user interactions.
    Difference
    0.1%
    Check dated 2026-05-18T04:00:35.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    This change updates the page’s system/release revision label from v3.5.2 to v3.5.3, without altering the study record content.
    Difference
    0.1%
    Check dated 2026-04-26T15:16:14.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No substantive changes to content or features.
    Difference
    0.1%
    Check dated 2026-04-19T12:47:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.